|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
2
|
Brenner H, Rothenbacher D and Arndt V:
Epidemiology of stomach cancer. Methods Mol Biol. 472:467–477.
2009. View Article : Google Scholar
|
|
3
|
Forman D and Burley VJ: Gastric cancer:
global pattern of the disease and an overview of environmental risk
factors. Best Pract Res Clin Gastroenterol. 20:633–649. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Flegal KM, Carroll MD, Kit BK and Ogden
CL: Prevalence of obesity and trends in the distribution of body
mass index among US adults, 1999–2010. JAMA. 307:491–497. 2012.
|
|
5
|
Tilg H and Moschen AR: Adipocytokines:
mediators linking adipose tissue, inflammation and immunity. Nat
Rev Immunol. 6:772–783. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Calle EE and Kaaks R: Overweight, obesity
and cancer: epidemiological evidence and proposed mechanisms. Nat
Rev Cancer. 4:579–591. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang P, Zhou Y, Chen B, Wan HW, Jia GQ,
Bai HL and Wu XT: Overweight, obesity and gastric cancer risk:
results from a meta-analysis of cohort studies. Eur J Cancer.
45:2867–2873. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yakar S, Nunez NP, Pennisi P, et al:
Increased tumor growth in mice with diet-induced obesity: impact of
ovarian hormones. Endocrinology. 147:5826–5834. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qian SS, Gao J, Wang JX, Liu Y and Dong
HY: Establishment of a mouse forestomach carcinoma cell line (MFC)
with spontaneous hematogenous metastasis and preliminary study of
its biological characteristics. Zhonghua Zhong Liu Za Zhi.
9:261–264. 1987.(In Chinese).
|
|
10
|
Zyromski NJ, Mathur A, Pitt HA, et al:
Obesity potentiates the growth and dissemination of pancreatic
cancer. Surgery. 146:258–263. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kitayama J, Tabuchi M, Tsurita G, Ishikawa
M, Otani K and Nagawa H: Adiposity and gastrointestinal malignancy.
Digestion. 79:26–32. 2009. View Article : Google Scholar
|
|
12
|
Kitayama J, Hatano K, Kaisaki S, Suzuki H,
Fujii S and Nagawa H: Hyperlipidaemia is positively correlated with
lymph node metastasis in men with early gastric cancer. Br J Surg.
91:191–198. 2004. View
Article : Google Scholar
|
|
13
|
Moriwaki Y, Kunisaki C, Kobayashi S,
Harada H, Imai S and Kasaoka C: Does body mass index (BMI)
influence morbidity and long-term survival in gastric cancer
patients after gastrectomy? Hepatogastroenterology. 50:284–288.
2003.PubMed/NCBI
|
|
14
|
Ojima T, Iwahashi M, Nakamori M, et al:
Influence of overweight on patients with gastric cancer after
undergoing curative gastrectomy: an analysis of 689 consecutive
cases managed by a single center. Arch Surg. 144:351–358. 2009.
View Article : Google Scholar
|
|
15
|
Payer J, Jackuliak P and Nagyová M:
Obesity and a risk of carcinoma. Vnitr Lek. 56:1082–1087. 2010.(In
Slovak).
|
|
16
|
Pollak M: Insulin-like growth
factor-related signaling and cancer development. Recent Results
Cancer Res. 174:49–53. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Samal B, Sun Y, Stearns G, Xie C, Suggs S
and McNiece I: Cloning and characterization of the cDNA encoding a
novel human pre-B-cell colony-enhancing factor. Mol Cell Biol.
14:1431–1437. 1994.PubMed/NCBI
|
|
18
|
Fukuhara A, Matsuda M, Nishizawa M, et al:
Visfatin: a protein secreted by visceral fat that mimics the
effects of insulin. Science. 307:426–430. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim SR, Park HJ, Bae YH, et al: Curcumin
down-regulates visfatin expression and inhibits breast cancer cell
invasion. Endocrinology. 153:554–563. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim JG, Kim EO, Jeong BR, et al: Visfatin
stimulates proliferation of MCF-7 human breast cancer cells. Mol
Cells. 30:341–345. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Patel ST, Mistry T, Brown JE, Digby JE,
Adya R, Desai KM and Randeva HS: A novel role for the adipokine
visfatin/pre-B cell colony-enhancing factor 1 in prostate
carcinogenesis. Peptides. 31:51–57. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bi TQ and Che XM: Nampt/PBEF/visfatin and
cancer. Cancer Biol Ther. 10:119–125. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Reddy PS, Umesh S, Thota B, et al:
PBEF1/NAmPRTase/visfatin: a potential malignant
astrocytoma/glioblastoma serum marker with prognostic value. Cancer
Biol Ther. 7:663–668. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nakajima TE, Yamada Y, Hamano T, et al:
Adipocytokine levels in gastric cancer patients: resistin and
visfatin as biomarkers of gastric cancer. J Gastroenterol.
44:685–690. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nakajima TE, Yamada Y, Hamano T, et al:
Adipocytokines as new promising markers of colorectal tumors:
adiponectin for colorectal adenoma, and resistin and visfatin for
colorectal cancer. Cancer Sci. 101:1286–1291. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang Y, Daquinag A, Traktuev DO, et al:
White adipose tissue cells are recruited by experimental tumors and
promote cancer progression in mouse models. Cancer Res.
69:5259–5266. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang Y, Bellows CF and Kolonin MG:
Adipose tissue-derived progenitor cells and cancer. World J Stem
Cells. 2:103–113. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Comoglio PM and Trusolino L: Cancer: the
matrix is now in control. Nat Med. 11:1156–1159. 2005. View Article : Google Scholar : PubMed/NCBI
|
